Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the strategic acquisition of George King Bio-Medical, Inc., a provider of hemostasis diagnostic products with close ties to the bleeding disorders community. “Since its founding more than 50 years ago, George King Bio-Medical has remained true to its purpose—helping individuals affected by bleeding disorders,” comments Paul Empey, President and CEO of Precision BioLogic. “Our two organizations share a similar purpose. Together, we can continue to work with existing customers and partners while exploring new opportunities to help others in the bleeding disorders community.”
Read the full article: Precision BioLogic Acquires George King Bio-Medical //
Source: https://www.prnewswire.com/news-releases/precision-biologic-acquires-george-king-bio-medical-302585174.html